Business
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market. The shipment included 1,0
About this update from Hytn Innovations Inc
[{"type":"image","alt":"HYTN Innovations Inc.","displaySize":"","headline":null,"caption":"HYTN Innovations Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":267,"height":91,"url":"https://media.zenfs.com/en/globenewswire.com/d0d2c55d487605e813bedcd12be5d8b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WwJCiVlVdiZV0YtQRlnsrw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0Mw--/https://media.zenfs.com/en/globenewswire.com/d0d2c55d487605e813bedcd12be5d8b1","width":267,"height":91}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.","length":474,"tagName":"p"},{"type":"text","content":"The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability to supply finished non-sterile cannabis oil products in a market-ready format for international regulated distribution.","length":401,"tagName":"p"},{"type":"text","content":"This achievement follows a successful Health Canada a compliant rated inspection exit notice that expanded the Company’s Drug Establishment Licence (DEL) to include oil as both an active pharmaceutical ingredient (API) and a finished dosage form. These enhancements bolster HYTN’s GMP platform, enabling the production and export of oil-based cannabis products in both API and finished formats for regulated medical markets including Germany, the United Kingdom, and Australia.","length":477,"tagName":"p"},{"type":"text","content":"“The successful release of GMP finished vape cartridges is an important operational milestone for HYTN,” said Jason Broome, Chief Operating Officer of HYTN. “This was a full commercial batch – not bulk extract or a development run. These one-gram live resin cartridges were manufactured under GMP as finished goods and have no...